Home/Filings/4/0001999371-24-000974
4//SEC Filing

Radovich Peter 4

Accession 0001999371-24-000974

CIK 0001724979other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 4:49 PM ET

Size

14.6 KB

Accession

0001999371-24-000974

Insider Transaction Report

Form 4
Period: 2024-01-26
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-01-2620,0000 total
    Exercise: $2.44Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-01-2613,8900 total
    Exercise: $3.95Common Stock (13,890 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-01-2635,0000 total
    Exercise: $1.21Common Stock (35,000 underlying)
  • Disposition from Tender

    Common Stock, par value $0.001 per share

    2024-01-268,7960 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-01-2642,5960 total
    Exercise: $3.13Common Stock (42,596 underlying)
Footnotes (2)
  • [F1]This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. ("Parent") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), dated as of December 13, 2023 (the "Merger Agreement"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the "Effective Time"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right.
  • [F2]Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration.

Documents

1 file

Issuer

Rain Oncology Inc.

CIK 0001724979

Entity typeother

Related Parties

1
  • filerCIK 0001650131

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:49 PM ET
Size
14.6 KB